A Closer Look At China’s First Provincial Medical Device Tender In 2012
This article was originally published in PharmAsia News
China begins device tender process, and with the first province results in, cuts are not as deep as expected.
You may also be interested in...
The first company to enter the drug-eluting stent market will now be the first to depart.
China's Leading Medical Consumables Device Maker Weigao Plans New Share Offering In Hong Kong; JV With MNCs To Explore New Landscape
SHANGHAI - Weihai-based Shandong Weigao Group Medical Polymer Company Limited, the leading Chinese medical consumables manufacturer and Medtronic Inc., which holds 15% of its total stake, is planning a secondary offering of 85.6 million H shares in Hong Kong to raise roughly HK$1.736 billion ($223 million) to expand its production capability and fund potential merger and acquisitions
Increasingly looking to China to commercialize their latest therapies, multinationals may be leaping into unknown waters to navigate an intellectual property judiciary and administrative maze, in a country where some copy drugs have been approved before patent expiry. With a government trying to balance innovation and access, two recent rulings involving AstraZeneca shed rare light onto China’s protections for innovation, with advisors pointing to challenges and success factors.